Glesatinib
Product Specifications
CAS Number
936694-12-1
Synonyms
MGCD265
SKU
C01629-5mg
Target
C-Met
Applications
Protein Tyrosine Kinase
Additionnal Information
Glesatinib (MGCD265) is an orally bioavailable potent dual inhibitor of c-MET and SMO. Glesatinib counteracts P-glycoprotein (P-gp) mediated multidrug resistance (MDR) in non-small cell lung cancer (NSCLC) .
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1401630-01 0.02 mg (E-Coli)
Recombinant Pyrococcus abyssi Uncharacterized ATP-binding protein PYRAB12000 (PYRAB12000)
Sign In for Pricing
View Details MBS1401630-02 0.02 mg (Yeast)
Recombinant Pyrococcus abyssi Uncharacterized ATP-binding protein PYRAB12000 (PYRAB12000)
Sign In for Pricing
View Details MBS1401630-03 0.1 mg (E-Coli)
Recombinant Pyrococcus abyssi Uncharacterized ATP-binding protein PYRAB12000 (PYRAB12000)
Sign In for Pricing
View Details MBS1401630-04 0.1 mg (Yeast)
Recombinant Pyrococcus abyssi Uncharacterized ATP-binding protein PYRAB12000 (PYRAB12000)
Sign In for Pricing
View Details MBS1401630-05 0.02 mg (Baculovirus)
Recombinant Pyrococcus abyssi Uncharacterized ATP-binding protein PYRAB12000 (PYRAB12000)
Sign In for Pricing
View Details